Greener Journal of Medical Sciences

Excellence and Timeliness


Choose Language



Greener Journal of Medical Sciences

Vol. 11(1), pp. 46-72, 2021

ISSN: 2276-7797

Copyright ©2021, the copyright of this article is retained by the author(s)







Prevalence and Pattern of Dermatophytosis in Patients with Human Immunodeficiency Virus Infection Seen in The University of Port Harcourt Teaching Hospital, (UPTH) Port- Harcourt



Amaewhule MN



Department of Internal Medicine, Rivers State University Teaching Hospital.






Article No.: 040421032

Type: Research


Background: Immunosuppression due to various aetiologies have been associated with the occurrence of dermatophytosis. Several studies in the past have demonstrated that Human Immunodeficiency Virus (HIV) infection is a risk factor for the acquisition and severity of dermatophytosis.

Aim: This study examined the prevalence and pattern of dermatophytosis among patients with HIV infection in the University of Port - Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria.

Method: This was a cross-sectional study carried out in Port Harcourt over a 6 month period involving 173 HIV sero-positive cases and 173 seronegative controls subjects. They were interviewed with a structured questionnaire and thereafter screened for the presence of dermatophytosis. Samples were collected from those with clinically diagnosed dermatophytosis and sent for mycology studies. Information were anaylsed using SPSS version 20.

Results: There was a higher prevalence of dermatophytosis in the HIV seropositive group when compared to the HIV seronegative control made up of HIV seronegative subjects. Most of the lesions seen were not markedly different from that seen in immunocompetent persons. 41.65% of the cases were found among those with Cd4 cell counts  below 200cells/µl. Tinea corporis was the commonest lesion seen (50%). Trichophyton species was the commonest dermatophyte isolated, followed by Microsporum species.

Conclusion: The prevalence of dermatophytosis is significantly higher in HIV infected patients and commonly occurs in advanced stages of the disease. Tinea corporis is the most common lesion in this group of patients and Trichophyton species a common causative agent. 


Accepted:  05/04/2021

Published: 08/04/2021


*Corresponding Author

Amaewhule MN MBBS, FWACP

E-mail: nnendamary@



prevalence; pattern; dermatophytosis; HIV; UPTH




Return to Content       View [Full Article - PDF]  

[Full Article - HTML]              [Full Article - EPUB]





(1.) Christine MP. Geographical distribution of the dermatophytes: A review. J. Hyg. Camb. 1978. 80: 301-310.


(2.) Nweze EI, Okafor JI. Increasing cases of tinea capitis  dermatophytosis in children of school age in Nigeria. (2007). Second Pan African medical mycology society conference, Cape Town. South Africa.


(3.)  Odunowo DB, Pattern of Dermatophytosis among out-patients seen in Lagos university teaching hospital skin clinic. (1988)  pg92.


(4.) Jacobs PH. Dermatophytes that infect animals and humans. Cutis, 1988; 42:130-131.


(5.) Olumide YM. A pictorial self-instructional manual on common skin diseases (where there is no dermatologist). College of Medicine of the University of Lagos Press 1990.15-23.


(6.) Mackenzie DWR. "Hairbrush diagnosis" in detection and eradication of non-fluorescent scalp ringworm. British medical Journal 1963; 2: 363-365.


(7.) Rothman S, Smiljanic L, Shapiro L, Weitkamp AW. The spontaneous cure of tinea capitis in puberty. J. Invest. Dermatol. 1947. 8: 81-98.


(8.) Calderon RA, Hay RJ. Fungicidal activity of human neutrophils and monocytes on dermatophyte fungi, Trichophyton quinckeanum and Trichophyton rubrum. Immunology 1986; 61: 289–95.)


(9.) Hay RJ, Reid S, Talwat E, Macnamara K. Immune responses of patients with tinea imbricata. Br J Dermatol 1983; 108: 581–9.


(10.) Calderon RA, Hay RJ. Cell-mediated immunity in experimental murine dermatophytosis.II. Adoptive transfer of immunity to dermatophyte infection by lymphoid cells from donors with acute or chronic infections. Immunology 1984;53: 405–10.


(11.) Jones HE, Reinhardt JH, Rinaldi MG. Acquired immunity to dermatophytosis. Arch Dermatol 1974; 109: 840–8.


(12.) Hay RJ, Shennan G. Chronic dermatophyte infections. II. Antibody and cell mediated immune responses. Br J Dermatol. 1982; 106: 191–5.


(13.) Serjeantson S, Lawrence G. Autosomal recessive inheritance of susceptibility to tinea imbricata. Lancet 1977; 1: 13–15.


(14.) Gilchrest BA. Some gerontologic considerations in the practice of dermatology. Arch. Dermatol.1979;155:1343-1346.


(15.) Hay RJ. Chronic dermatophyte infections. I. Clinical and mycological features. Br J Dermatol 1982; 106: 1–6.


(16.) Canizares O, Shatin H, Kellert AJ. Cushing,s syndrome and dermatomycosis. Arch. Dermatol.1959.80:705-715.


(17.)  Torssander J, Karlsson A, Morfeldt-Månson L, Putkonen PO, Wasserman J. Dermatophytosis in HIV infection: a study in homosexual men. Acta Derm. Venereal (Stockti) 1998; 68: 53 – 56.


(18.) Allen AM, King RD. Occlusion, carbon dioxide and fungal skin infections. Lancet1978; 1: 360–2.


(19.) Allan Ll, Sung Huang S. Dermatophyte Viability at Modestly Raised Temperatures Arch Dermatol. 1963; 88(4):393-402.


(20.)  CDC (Centre for Disease Control) (1981c) follow up on Kaposi Sarcoma and pneumocystic pneumonia. MMWR (Morbidity and Mortality weekly Report) 1981; 30; 409 – 410.


(21.) Centre For Disease Control (1981) Kaposi Sarcoma and pneumocystic pneumonia among homosexual men – New York City and California MMWR. 1981; 30: 305-308


(22.) Centre For Disease Control (1981a). Pneumocystic pneumonia – Los Angeles MMWR 1981; 30: 250 – 252.


(23.) Barré-Sinoussi  F, Chermann  JC, Rey F, Nugeyre  MT, Chamaret  S, Gruest  J, et al . Isolation of a T-Lymphotrophic retrovirus from a patient at risk for AIDS. Science 1983, 220: 868 – 871.


(24.) Broder S, Gallo RC, A pathogenic retrovirus (HTLV III). Linked to AIDS. New England Journal of Medicine 1984, 311: 1292 – 1297.


(25.) Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV – III) from patients with AIDS and at risk for AIDS. Science 1984, 224: 500 – 503.


(26.)  UNAIDS Report on the global AIDS epidemic | 2020.


(27.)National Agency for the Control of AIDS (NACA). Federal Republic of Nigeria. Global AIDS response. Country Progress Report. Nigeria GARPR. 2012. P 16-17.


(28.) Braathen LR, Kaanan T. Human epidermal langerhan’s cells induce cellular immune responses to trichopyton in dermatophytosis. Br. J. Dermatol. 1983; 109; 295 – 9.


(29.) Groh V, Mann DL. Langerhan’s cells in HIV-I infection. J. Am. Acad. Dermatol., June 1996; 134(6) 1122 – 1124.


(30.) Stingl G, Rappersberger K, Tschachler E, Gartner S, Groh V, Mann DL, et al. Langerhan cell in HIV I infection. J. Am. Acad. Dermatol. 1990; 22: 1210 – 1217.


(31.) Reeves, J. D.  Doms, R. W. "Human Immunodeficiency Virus Type 2". J. Gen. Virol. 2002. 83 (Pt 6): 1253–65.



(32.)Thomson MM, Perez-Alvarez L, Najera R (2002). "Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy". Lancet Infectious Diseases 2002. (8): 461–471.  


(33.) Carr JK, Foley BT, Leitner T, Salminen M, Korber B, McCutchan F. "Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic" (PDF). In Los Alamos National Laboratory (ed.). HIV sequence compendium. Los Alamos, New Mexico: Los Alamos National Laboratory. 1998.  pp. 10–19.


(34.) Markowitz, edited by William N. Rom ; associate editor, Steven B. Environmental and occupational medicine (4th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. . 2007. p. 745.


(35.) Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M  . "Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies". The Lancet Infectious Diseases 2009. (2): 118–129.) 


(36.) HIV in the United States: An Overview". Center for Disease Control and Prevention. March 2012.


(37.) Fiona Samuels and Sanju Wagle 2011. Population mobility and HIV and AIDS: review of laws, policies and treaties between Bangladesh, Nepal and India. London: Overseas Development Institute).


(38.) Coutsoudis A, Kwaan L, Thomson M."Prevention of vertical transmission of HIV-1 in resource-limited settings". Expert review of anti-infective therapy 8 .2010 Oct (10): 1163–75.


(39.) Baggaley, RF; Boily, MC; White, RG; Alary, M. "Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis". AIDS (London, England) 2006: 20 (6): 805–12).


(40.) Kripke, C . "Antiretroviral prophylaxis for occupational exposure to HIV.". American family physician 2007.76 (3): 375–6.


(41.) Parren PW, Moore J, Burton D, Sattentau Q. The neutralising antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 1999; 13: S137–S162.


(42.) Wilkinson J, Gotch FM. Immune interventions. Br Med Bull 2001; 58: 187–203.


(43.) Meinl E, Fickenscher H, Thome M, Tschopp J, Fleckenstein B. Anti-apoptotic strategies of lymphotropic viruses. Immunol. Today 1998; 19: 474–9.


(44.) Veazey R, Lackner A. The mucosal immune system and HIV.1 infection. AIDS Rev. 2003; 5: 245–52.


(45.) World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children; 2007.


(46.) Fauci AS, Clifford Lane H. HIV disease, AIDS and related disorders. In Braunwald E, Hanser SL, Fauci AS, Long DL, Kasper DL, Jameson JL, Editors, Harrison’s Principle of Internal Medicine 15th Edition. New York Mc-Graw Hill Vol. 2 P. 1852 – 1912.


(47.) Olumide YM, Dada AJ, Sogbanmu TB, Aruna GB. Seroprevalence study of HIV I, HIV II & HTLV I among patients at the Dermatovenerology Clinic of the Lagos University Teaching Hospital. Int. J. Dermatol. 1999 Oct; 36 (10): 741 – 4.


(48.) Yahaya H. Change in pattern of skin disease in Kaduna, North Central Nigeria. Int. J. Dermatol. 2007 Sept; 46(9): 936 – 43.


(49.) Ogunbiyi AO, Daramola OO, Alese OO. Prevalence of skin diseases in Ibadan Nigeria. Int. J. Dermatol. 2004 Jan. 43(1): 31 – 6.


(50.) Goodman  DS, Teplitz  ED, Wishner  A, Klein  RS, Burk  PG, Hershenbaum E. Prevalence of cutaneous disease in patients with AIDS  or AIDS Related Complex. J. Am. Acad. Dermatology. 1987; 17:210 – 220.


(51.) Nnoruka EN, Chukwuka JC, Anisiuba B. Correlation of mucocutaneous manifestation of HIV/AIDS infection with CD4 Counts and disease progression. Int.J. Dermatol. 2007 Oct. 46 Suppl. 2, 14–8.                                           


(52.) Shobhana A, Guha SK, Neogi, DK. Mucocutaneous manifestations of HIV infection. Indian Journal of Dermatology Venerology and Leprology. Vol. 70; No 2. March – April 2004. Pp 82-86


(53.)  Aly R, Berger T. Common Superficial fungal infections in patients with AIDS. Clinical Infectious Disease. 1996; 22: 5128 – 5132.


(54.) Ajao AO, Akintunde C. Studies on the prevalence of tinea capitis infection in Ile-Ife, Nigeria. Mycopathologica 1985, Jan;89(1): 43-8.


(55.) Ameh IG, Okolo RU. Dermatophytosis among school children in Nigeria: Domestic animals as predisposing factors in Sokoto, Nigeria. Pakistan Journal of biological sciences 2004 (7); 1109-1112..


(56.) Sanuth HA, Efuntoye M.O. Distribution and microbiological characteristics of dermatophyte infection among primary school children in Ago-Iwoye, Oguun state, Nigeria. Researcher. 2010: 2(12): 80-85.


(57.) Ndako JA, Osemwegie OO, Spencer TH, Olopade BK, Yunusa GA, Banda J. Prevalence of dermatophytosis and other associated fungi among school children. Global advanced research journal of medicine and medical sciences. Vol. 1(3) pp.049-056, April 2012.


(58.) Akinboro AO, Olasode AO, Onayemi O. The pattern, risk factors and clinico-aetiological correlates of tinea capitis among the children in a tropical community setting of Osogbo, Southwestern Nigeria. Afro-Egypt J. Infect. Endem. Dis. 2011, 1(2): 53-64.


(59.) David DL, Edward A, Zaruwa MZ, Addas PA. Barbing salon associated fungal disease infection in Mubi, Adamawa state, Nigeria. World journal of medical sciences, 5(1): 17-21, 2010.


(60.) Soyinka F. Epidemiological study of dermatophyte infections in Nigeria (clinical survey and laboratory investigations). Mycopathologia 1978. July 28; 63 (2) 99-103. (61.)  Zurita J, Hay RJ. The adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J. Invest, Dermatol. (1987); 89: 529-534.


(62.)  Al Jabre SH, Richardson MD, Scott EM, Rashid A, Shankland GS. Adherence of arthroconidia and germlings of anthropophilic and zoophilic varieties of Trichophyton mentagrophytes to human corneocytes as an early event in the pathogenesis of dermatophytosis. Clin Exp Dermatol 1993; 18: 231–5.


(63.) Blank H, Sagami S, Boyd C, Roth FJ. The pathogenesis of superficial fungal infections in cultured human skin. Archives of Dermatology, 1959; 72: 524-535.


(64.) Lorincz AL, Priestly JO, Jacobs PH. Evidence for a humoral mechanism which prevents growth of dermatophytes. Journal of Investigative Dermatology, 1958; 31:15-17. 


(65.) Raubitschek F, Maoz R. Invasion of nails in vitro by certain dermatophytes. J. Invest Dermatol 1957; 28: 261–8.


(66.) Lambkin E, Hamilton A, Hay RJ. Partial purification and characterization of a 235 000 Mr extracellular proteinase from  Trichophyton rubrum. Mycoses 1994; 37: 85–92.


(67.) Yu RJ, Harmon SR, Grappel SF. Two cell bound keratinases of Trichophyton mentagrophytes. J Invest Dermatol 1971; 56: 27–32.


(68.) Siesenop U, Bohm KH. Comparative studies on keratinase production of Trichophyton mentagrophytes of animal origin. Mycoses 1995; 38: 205–9.


(69.) English MP. Nails and fungi. Br J Dermatol 1976; 74: 697–701


(70.) Kaviarasan PK, Jaisankar TJ, Thappa DM, Sujatha S. Clinical Variations in Dermatophytosis in HIV infected patients. Indian Journal of Dermatology, Venerology and Leprology 2002, 68: 213 – 216.


(71.)  Ekong , A. Uwa, and I. Grant – Prevalence and types of opportunistic infections in HIV/AIDS patients in Nigeria. 5th International Congress on Drug Therapy in HIV infection. 22 – 26 October 2000 Glasgow UK.


(72.) Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D,  et al, Cutaneous findings in HIV I positive patients a 42 month prospective study. Military Medical Consortium for the advancement of retroviral research (MMCARR) J. Am. Acad. Dermatol. 1994; 31: 746 – 754.


(73.)  Berger TG, Greene I.  Bacterial, Viral, Fungal and Parasitic infections in HIV disease and AIDS. Dermatol. Clin. 1991; 9: 465 – 492.


(74.)  Muñoz-Pèrez MA, Rodriguez-Pichardo A, Camacho F, Rios JJ. Extensive and deep dermatophytosis caused by Trichophyton Mentagrophytes var interdigitale in an HIV – I positive patient. Journal of the European Academy of Dermatology and Venerology . 2000.14 (1): 61 – 63.


(75.) Kwon KS, Jang HS, Son HS, Oh CK, Kwon YW, Kim KH, et al. Widespread and invasive Trichophyton Rubrum  infection mimicking Kaposi Sarcoma in a patient with AIDS. J. Dermatol. 2004. October; 31 (10): 839 – 843.


(76.)  Vilela  R, Oliveira TF, Vilela  L,  Mendoza  L. Exacerbated inflammatory reaction to Trichophyton rubrum infection on an HIV-positive patient successfully treated with fluconazole Mycopathologica Vol. 163. No 4, April 2007 page 208 – 205.


(77.) Porro AM, Yoshioka MC, Kaminski SK, Palmeira Mdo C, Fischman O, Alchorne MM. Disseminated dermatophytosis caused by Microsporum gypseum in 2 patients with AIDS. Mycopathologica 1997; 137 (1) 9 – 12.


(78.)  Nenoff P, Graser Y, Kibuka – Serunkuma L, Muylowa, GK. Tinea circinata manus due to microsporum gypseum in an HIV positive boy in Uganda East Africa. Mycosis. Vol. 50; No 2 March 2007, Pp 1 53 – 155.


(79.)  Nuniman C, Fernandez, Fabriciolamy, Tiyomi Akiti – Microsporum gypseum infection in AIDS patient. A case report. Anais brasileires de  dermatologica. Vol. 73 No 1, (Jan/Feb 1998).


(80.)   Menon T, Ranganathan S.  Extensive T. Corporis caused by Trichophyton verrucosum in a patient with HIV infection. Indian Journal of Dermatol. Venerol and Leprol. 1996; 62: 126 – 127.


(81.)  Lowinger Seoane M, Torres-Rodriguez JM, Madrenys-Brune N, Aregall-Fuste S, Saballs P.  Extensive dermatophytosis caused by Trichophyton Mentagrophytes and Microsporum Canis in a patient with AIDS. Mycopathologica, 1992 Dec. 120 (3): 143 – 146.


(82.)  Rothman S, Smiljame A, Shapiro AL, Weltkamp AW, The spontaneous cure of Tinea capitis at puberty. J. Invest. Dermatol. 1947; 8: 81 – 98.


(83.) Tinea Capitis in adults and adolescents. Arch. Dermatol. Syphilol. 1952; 65: 9 – 40.


(84.)  Gremer G, Bournerias I, Vandeleme-Ubroucke E, Hourn R, Revur J, Tinea Capitis in adults – misdiagnosis or reappearance. Dermatology 1997; 194: 8 – 11.


(85.)  Lateur N, Andre J, De Maubeuge J, Poncin M, Song M, Tinea Capitis in 2 black African adults with HIV infection. Br. J. Dermatol. 1999 April; 140(4): 722 – 724.


(86.) Bournias I, Dechauwin MF, Datry A, Chambrette I, Camiere J, Deridas A, et al. Unusual microsporum caris infections in adult HIV infected patients. J. Am. Acad. Dermatol. 1996 Nov.; 35 (5p+2) 808 – 810.


(87.) Gregory N. Special patient populations: onychomycosis in the HIV positive patient. J. Am. Acad. Dermatol. 1996; 35: 813 – 816.


(88.) Levy LA, Epidemiology of onychomycosis in special risk populations. J. Am. Paediatric Medical Association. 1997; 87: 546 – 550.


(89.) Dompmartin D, Dompmartin  A, Deluol AM, Grosshans E, Coulaud JP. Onychomycosis  in AIDS - Clinical and laboratory findings in 62 patients. Int. J. of Dermatol. 1990 June, 29 (5) 337 – 339.


(90.) Odom RB.  Common superficial fungal infections in immunosuppressed patients. J. Am. Acad. Dermatology 1994; 31: 856 – 859.


(91.)  Daniel CR, Norton LA, Scher RK. The Spectrum of nail disease in patients with HIV. J. Am. Acad. Dermatol 1992; 27: 93 – 97.


(92.) Raninborg  L, Baastrup N, Svejguard E. Onychomycosis in HIV infected patients. Acta Dermatol. Venerol. 1998; 78: 151 – 152.


(93.) Svejgaard E. Recent trends in the immunology of dermatophytes. Microbial. Sci. 1986; 3: 154 – 159.


(94.) Popoola DA, Ojo DA,  Alabi RO, Prevalence of dermatophytosis in junior secondary school children in Ogun state Nigeria. Mycoses. 2006. Vol.49 issue 6.:499-502.


(95.)  Ozumba UC, Nlemadim R. Prevalence of dermatophytosis in University of Nigeria Teaching Hospital, Enugu, Nigeria. Any change in pattern. Niger. J. Clin.Pract. 2005.  Dec. 8(2):83-88.


(96.) Coldrion  BM, Bergshesser  PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch. Dermatol. 1989. 125:357-61.


(97.) Pennys NS. Skin manifestation of AIDS. London Martin. Dumitz 1995.


(98) Ho KM,  Wong KH. Dermatological Manifestations in HIV disease. In Chan KLW, Wong KH, Lee SS, eds. HIV manual 2001.pp 231-245.


(99.) Raju PV, Rao GR, Ramari TV, Vandana S. Skin disease: Clinical indicator of immunostatus in human immunodeficiency virus (HIV) infection. Int J. Dermatol.2005; 44:646-9.



(100.) Kumarasamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP, Yesudian P.  Dermatologic  manifestations among human immunodeficiency virus patients in South India. Int J. Dermatol.2000: 39:192-195.


(101.) Singh A, Thappa DM, Hamide A. The spectrum of mucocutaneous manifestations during the evolutionary phases of HIV disease. An emerging Indian scenario. J. Dermatol. (Tokyo)1999;26: 294-304.


(102.) Rajesh R, Subramanian K, Padmavasthy BK, Vasanthi S. Prevalence and specie profile of dermatophytosis among HIV positive patients in a rural referral centre. Indian J. Sex. Transm. Dis. 2006; vol. 27 No 2p70.


(103.) Satiya VSA, Singh VP, Shyam S, Gulati AK, Varma DV, Rai M. Relationship between skin diseases and cd4 cell count in a hospital based cohort of HIV infected adults in North India.Journal ,Indian Academy of clinical medicine. March 2008. Vol 9, No 1Jan- p 20-25.


(104) Conant MA. The AIDS Epidemic. J Am Acad Dermatol 1994 Sep;31(3pt2):47-50.


(105.) Umoru DD, Esene H. Clinical characteristics of dermatophytosis among children in a Nigeria population; the role of HIV/AIDS Benin journal of postgraduate medicine. vol 12 no 1 Dec. 2010. p 32-36.


(106.) Daniel CR III, Gupta AK, Daniel MP, Daniel CM. Two feet-one hand syndrome: a retrospective multicenter survey. Int J Dermatol. 1997;36:658-660


(107.)Silva-Tavares H, Alchorne MM, Fischman O. Tinea cruris epidemiology (São Paulo, Brazil). Mycopathologia. 2001;149:147-149.)


(108.)   Adriano S, Valeri B, Giuliano B, Gingio B, Anna M, Severino S. Prevalence of dermatophytosis and yeasts in HIV patients . Mycopathologia vol. 14, No 2, 103-107,d01.1007/BF0043629.


(109.) Amar S, Ratnakar K ,Chetan O, Dattatray S, Minal T, Sujata T et al. A clinical and mycological study of onychomycosis in HIV infection Indian J.  Dermatol. Venereal.  Leprol. 2007 397-401.


Bottom of Form

(110) Bakos L, Bonamigo RR. Pisani AC. Mariante JC, Mallman R. Scutular favus-like tinea cruris and pedis in a patient with AIDS. J Am Acad Dermatol 1996;34:1086-7.


(111.) Primary  cutaneous aspergillosis in Human Immunodeficiency virus -infected patients. Clinical infectious Diseases. Sep 1998. Vol. 27. No 3:p641-643.



Cite this Article: Amaewhule MN (2021). Prevalence and Pattern of Dermatophytosis in Patients with Human Immunodeficiency Virus Infection Seen in The University of Port Harcourt Teaching Hospital, (UPTH) Port- Harcourt. Greener Journal of Medical Sciences, 11(1): 46-72.



Call for Papers

Call for Scholarly Articles

Authors from around the world are invited to send scholary articles that suits the scope of this journal. The journal is currently open to submissions and will process and publish articles monthly in two yearly issues.

The journal is centered on quality and goes about its processes in a very timely fashion. Seasoned editors/reviewers will be consulted to review each article(s), profer quality evaluations and polish the articles with expertise before publication.

Simply send your article(s) as an e-mail attachment to or



Login Form

Other Journals